Does glucocorticoid therapy in the peri-implantation period have an impact on IVF outcomes?

Current Opinion in Obstetrics and Gynecology

Volumn 20, Issue 3, 2008, Pages 249-256

  Boomsma, Carolien M ^a   Macklon, Nick S ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Assisted reproductive techniques; Corticosteroids; Glucocorticoids; Implantation; IVF

Indexed keywords

16BETA METHYLPREDNISOLONE; ACETYLSALICYLIC ACID; AUTOANTIBODY; BETAMETHASONE; CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; DEXAMETHASONE; FOLLITROPIN; GLUCOCORTICOID; GONADORELIN; GONADORELIN AGONIST; HUMAN MENOPAUSAL GONADOTROPIN; HYDROCORTISONE; LEUPRORELIN; METHYLPREDNISOLONE; PLACEBO; PREDNISOLONE; PREDNISONE; PROGESTERONE; SPERM ANTIBODY; TETRACYCLINE;

ABSENCE OF SIDE EFFECTS; ADJUVANT THERAPY; CLINICAL TRIAL; CONTUSION; CORTICOSTEROID THERAPY; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FEMALE INFERTILITY; FERTILIZATION; FERTILIZATION IN VITRO; GLYCEMIC CONTROL; HUMAN; INFECTION; INTRACYTOPLASMIC SPERM INJECTION; INTRAUTERINE GROWTH RETARDATION; LOW DRUG DOSE; NIDATION; NONHUMAN; OVARY; OVARY HYPERSTIMULATION; PEPTIC ULCER; PREGNANCY; PREGNANCY RATE; PREMATURITY; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE; ZONA PELLUCIDA;

BIRTH RATE; EMBRYO IMPLANTATION; FEMALE; FERTILIZATION IN VITRO; GLUCOCORTICOIDS; HUMANS; PREGNANCY; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 43149111500     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/GCO.0b013e3282f8aff5     Document Type: Review

References (54)

1. Boomsma CM, Macklon NS. What can the clinician do to improve implantation? Reprod Biomed Online 2006; 13:845-855.
2. Dey SK, Lim H, Das SK, et al. Molecular cues to implantation. Endocrine Rev 2004; 25:341-373.
3. Croy BA, Chantakru S, Esadeg S, et al. Decidual natural killer cells: key regulators of placental development (a review). J Reprod Immunol 2002; 57:151-168.
4. Ledee-Bataille N, Bonnet-Chea K, Hosny G, et al. Role of the endometrial tripod interleukin-18, -15, and -12 in inadequate uterine receptivity in patients with a history of repeated in vitro fertilization-embryo transfer failure. Fertil Steril 2005; 83:598-605.
5. Quenby S, Kalumbi C, Bates M, et al. Prednisolone reduces preconceptual endometrial natural killer cells in women with recurrent miscarriage. Fertil Steril 2005; 84:980-984.
6. Boomsma CM, Keay SD, Macklon NS. Peri-implantation glucocorticoid administration for assisted reproductive technology cycles. Cochrane Database Syst Rev 2007:CD005996. This meta-analysis summarizes the available RCTs on the use of glucocorticoids in the peri-implantation period. Pooling the results shows no significant beneficial effect in the general IVF/ICSI population, although a subgroup analysis of women undergoing IVF did show a borderline significant effect of glucocorticoids on pregnancy rates.
7. Ando T, Suganuma N, Furuhashi M, et al. Successful glucocorticoid treatment for patients with abnormal autoimmunity on in vitro fertilization and embryo transfer. J Assist Reprod Genet 1996; 13:776-781.
8. Bider D, Amoday I, Tur-Kaspa I, et al. The addition of a glucocorticoid to the protocol of programmed oocyte retrieval for in-vitro fertilization: a randomized study. Hum Reprod 1996; 11:1606-1608.
9. Bider D, Amoday I, Yonesh M, et al. Glucocorticoid administration during transfer of frozen-thawed embryos: a prospective, randomized study. Fertil Steril 1996; 66:154-156.
10. Botti G, Fugueroa Casas PR, Tozzini I, et al. Effect of glucocorticoid therapy on embryo implantation [abstract]. Fertil Steril Abstract Book 1998:s423.
11. Catt JW, Ryan JP, Saunders DM, O'Neill C. Short-term corticosteroid treatment does not improve implantation for embryos derived from subzonal insertion of sperm. Fertil Steril 1994; 61:565-566.
12. Duvan CI, Ozmen B, Satiroglu H, et al. Does addition of low-dose aspirin and/or steroid as a standard treatment in nonselected intracytoplasmic sperm injection cycles improve in vitro fertilization success? A randomized, prospective, placebo-controlled study. J Assist Reprod Genet 2006; 23:15-21.
13. Ezzeldin F, Rahman AF, Agameya AF, et al. Prednisolone administration in the luteal phase in ICSI [abstract]. Hum Reprod Abstract Book 2003; 18:116.
14. Kemeter P, Feichtinger W. Prednisolone supplementation to Clomid and/or gonadotrophin stimulation for in-vitro fertilization: a prospective randomized trial. Hum Reprod 1986; 1:441-444.
15. Kim CH, Chae HD, Kang BM, et al. The immunotherapy during in vitro fertilization and embryo transfer cycles in infertile patients with endometriosis. J Obstet Gynaecol Res 1997; 23:463-470.
16. Moffitt D, Queenan JT Jr, Veeck LL, et al. Low-dose glucocorticoids after in vitro fertilization and embryo transfer have no significant effect on pregnancy rate. Fertil Steril 1995; 63:571-577.
17. Mottla GL, Smotrich DB, Gindoff PR, Stillman RJ. Increasing clinical pregnancy rates after IVF/ET. Can immunosuppression help? J Reprod Med 1996; 41:889-891.
18. Tan SL, Balen A, el Hussein E, et al. The administration of glucocorticoids for the prevention of ovarian hyperstimulation syndrome in in vitro fertilization: a prospective randomized study. Fertil Steril 1992; 58:378-383.
19. Ubaldi F, Rienzi L, Ferrero S, et al. Low dose prednisolone administration in routine ICSI patients does not improve pregnancy and implantation rates. Hum Reprod 2002; 17:1544-1547.
20. Mollo A, Strina I, Alviggi C, et al. Effect of low dose aspirin and prednisone administered after ovum pick-up on implantation and abortion rates in women with no auto-immune disorders undergoing ICSI. Giorn It Ost Gin 2002; 14:261-265.
21. Stern C, Chamley L, Hale L, et al. Antibodies to [beta]2 glycoprotein I are associated with in vitro fertilization implantation failure as well as recurrent miscarriage: results of a prevalence study. Fertil Steril 1998; 70:938-944.
22. Reimand K, Talja I, Metskula K, et al. Autoantibody studies of female patients with reproductive failure. J Reprod Immunol 2001; 51:167-176.
23. Taylor PV, Campbell JM, Scott JS. Presence of autoantibodies in women with unexplained infertility. Am J Obstet Gynecol 1989; 161:377-379.
24. Dmowski WP, Rana N, Michalowska J, et al. The effect of endometriosis, its stage and activity, and of autoantibodies on in vitro fertilization and embryo transfer success rates. Fertil Steril 1995; 63:555-562.
25. Taniguchi F. Results of prednisolone given to improve the outcome of in vitro fertilization: embryo transfer in women with antinuclear antibodies. J Reprod Med 2005; 50:383-388.
26. Lockwood CJ, Reece EA, Romero R, Hobbins JC. Antiphospholipid antibody and pregnancy wastage. Lancet 1986; 2:742-743.
27. Rand JH, Wu XX, Andree HA, et al. Pregnancy loss in the antiphospholipid-antibody syndrome: a possible thrombogenic mechanism. N Engl J Med 1997; 337:154-160.
28. Geva E, Amit A, Lerner-Geva L, et al. Prednisone and aspirin improve pregnancy rate in patients with reproductive failure and autoimmune antibodies: a prospective study. Am J Reprod Immunol 2000; 43:36-40.
29. Hasegawa I, Yamanoto Y, Suzuki M, et al. Prednisolone plus low-dose aspirin improves the implantation rate in women with autoimmune conditions who are undergoing in vitro fertilization. Fertil Steril 1998; 70:1044-1048.
30. Shohayeb A, Demerdash T. Effects of corticosteroids in hypothyroid patients with antithyroid antibodies on IVF outcome [abstract]. Hum Reprod Abstract Book; 2005.
31. Gobert B, Barabarino-Monnier P, Guillet-Rosso F, et al. Ovary antibodies after IVF. Lancet 1990; 335:723.
32. Narayanan M, Murthy PS, Munaf SA, et al. Antiovarian antibodies and their effect on the outcome of assisted reproduction. J Assist Reprod Genet 1995; 12:599-605.
33. Forges T, Monnier-Barbarino P, Guillet-May F, et al. Corticosteroids in patients with antiovarian antibodies undergoing in vitro fertilization: a prospective pilot study. Eur J Clin Pharmacol 2006; 62:699-705.
34. Geva E, Fait G, Lerner-Geva L, et al. The possible role of antiovary antibodies in repeated in vitro fertilization failures. Am J Reprod Immunol 1999; 42:292-296.
35. Naz RK. Modalities for treatment of antisperm antibody mediated infertility: novel perspectives. Am J Reprod Immunol 2004; 51:390-397.
36. Smarr SC, Wing R, Hammond MG. Effect of therapy on infertile couples with antisperm antibodies. Am J Obstet Gynecol 1988; 158:969-973.
37. Hendry WF, Hughes L, Scammell G, et al. Comparison of prednisolone and placebo in subfertile men with antibodies to spermatozoa. Lancet 1990; 335:85-88.
38. Haas GG Jr, Manganiello P. A double-blind, placebo-controlled study of the use of methylprednisolone in infertile men with sperm-associated immunoglobulins. Fertil Steril 1987; 47:295-301.
39. Cohen J, Inge KL, Suzman M, et al. Videocinematography of fresh and cryopreserved embryos: a retrospective analysis of embryonic morphology and implantation. Fertil Steril 1989; 51:820-827.
40. Cohen J, Malter H, Elsner C, et al. Immunosuppression supports implantation of zona pellucida dissected human embryos. Fertil Steril 1990; 53:662-665.
41. Primi MP, Senn A, Montag M, et al. A European multicentre prospective randomized study to assess the use of assisted hatching with a diode laser and the benefit of an immunosuppressive/antibiotic treatment in different patient populations. Hum Reprod 2004; 19:2325-2333.
42. Tan BK, Vandekerckhove P, Keay SD. Glucocorticoid supplementation during ovarian stimulation for IVF or ICSI (Protocol). Cochrane Database of Systematic Reviews 2004.
43. Harlow CR, Jenkins JM, Winston RM. Increased follicular fluid total and free cortisol levels during the luteinizing hormone surge. Fertil Steril 1997; 68:48-53.
44. Keay SD, Harlow CR, Wood PJ, et al. Higher cortisol:cortisone ratios in the preovulatory follicle of completely unstimulated IVF cycles indicate oocytes with increased pregnancy potential. Hum Reprod 2002; 17:2410-2414.
45. Andersen CY, Hornnes P. Intrafollicular concentrations of free cortisol close to follicular rupture. Hum Reprod 1994; 9:1944-1949.
46. Fridstrom M, Carlstrom K, Sjoblom P, Hillensjo T. Effect of prednisolone on serum and follicular fluid androgen concentrations in women with polycystic ovary syndrome undergoing in-vitro fertilization. Hum Reprod 1999; 14:1440-1444.
47. Bider D, Blankstein J, Levron J, Tur-Kaspa I. Gonadotropins and glucocorticoid therapy for "low responders": a controlled study. J Assist Reprod Genet 1997; 14:328-331.
48. Rein MS, Jackson KV, Sable DB, et al. Dexamethasone during ovulation induction for in-vitro fertilization: a pilot study. Hum Reprod 1996; 11:253-255.
49. Kim CH, Cho YK, Mok JE. The efficacy of immunotherapy in patients who underwent superovulation with intrauterine insemination. Fertil Steril 1996; 65:133-138.
50. Beitins IZ, Bayard F, Ances IG, et al. The transplacental passage of prednisone and prednisolone in pregnancy near term. J Pediatr 1972; 81:936-945.
51. Park-Wyllie L, Mazzotta P, Pastuszak A, et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology 2000; 62:385-392.
52. Pinsky L, Digeorge AM. Cleft palate in the mouse: a teratogenic index of glucocorticoid potency. Science 1965; 147:402-403.
53. Empson M, Lassere M, Craig JC, Scott JR. Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials. Obstet Gynecol 2002; 99:135-144.
54. Seckl J. Prenatal glucocorticoids and long-term programming [abstract]. Eur J Endocrinol 2004; 151:U49-U62.